Pharmacoeconomics : (Record no. 130594)

000 -LEADER
fixed length control field 03145cam a2200493Ii 4500
001 - CONTROL NUMBER
control field 9780429491368
003 - CONTROL NUMBER IDENTIFIER
control field FlBoTFG
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20220509193132.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS--GENERAL INFORMATION
fixed length control field m o d
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr |n|||||||||
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 200815s2021 enka ob 001 0 eng d
040 ## - CATALOGING SOURCE
Original cataloging agency OCoLC-P
Language of cataloging eng
Description conventions rda
Transcribing agency OCoLC-P
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9780429491368
-- electronic book
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 0429491360
-- electronic book
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9780429957673
-- electronic book
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 042995767X
-- electronic book
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9780429957666
-- (electronic bk. : Mobipocket)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 0429957661
-- (electronic bk. : Mobipocket)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9780429957680
-- (electronic bk. : PDF)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 0429957688
-- (electronic bk. : PDF)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Cancelled/invalid ISBN 1138589837
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Cancelled/invalid ISBN 9781138589834
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)1183721518
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC-P)1183721518
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RS100
Item number .P433 2021eb
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED
Subject category code subdivision 071000
Source bisacsh
072 #7 - SUBJECT CATEGORY CODE
Subject category code MB
Source bicssc
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 615.1
Edition number 23
245 00 - TITLE STATEMENT
Title Pharmacoeconomics :
Remainder of title from theory to practice /
Statement of responsibility, etc edited by Renée J.G. Arnold.
250 ## - EDITION STATEMENT
Edition statement Second edition.
264 #1 -
-- Milton Park, Abingdon, Oxon ;
-- Boca Raton, FL :
-- CRC Press,
-- 2021.
300 ## - PHYSICAL DESCRIPTION
Extent 1 online resource.
336 ## -
-- text
-- txt
-- rdacontent
337 ## -
-- computer
-- c
-- rdamedia
338 ## -
-- online resource
-- cr
-- rdacarrier
520 ## - SUMMARY, ETC.
Summary, etc In this era of finite budgets, healthcare rationing, medication shortages, and the global aging and burgeoning of populations, numerous stakeholders in the healthcare arena must understand the basic principles of pharmacoeconomics and how these may be correctly applied to facilitate drug development, rationing, patient segmentation, disease management, and pricing model development. Pharmacoeconomics: From Theory to Practice, Second Edition focuses on how to more efficiently and rationally leverage these healthcare resources, not by restricting access to necessary services, but by using them more efficiently. This updated volume arms decision makers with the tools they need to make wise choices in an area where the stakes are extremely highthe health of the global population. Key Features: Introduces the major concepts and principles of Pharmacoeconomics Gives updated information about pharmacoeconomic models, value-based pricing, novel modelling methodologies and international utilization of these modalities in government, the pharmaceutical industry, and health care settings Demonstrates the full range of ethical and moral issues, as well as overall public health and commercial concerns that are often involved in decisions entailing pharmacoeconomic issues Presents both theory and methodology discussions, including real-world examples, in each chapter
588 ## -
-- OCLC-licensed vendor bibliographic record.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Drugs
General subdivision Cost effectiveness.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Pharmacy
General subdivision Economic aspects.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Decision making.
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element MEDICAL / Pharmacology
Source of heading or term bisacsh
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Arnold, Renee J. G.,
Relator term editor.
856 40 - ELECTRONIC LOCATION AND ACCESS
Materials specified Taylor & Francis
Uniform Resource Identifier https://www.taylorfrancis.com/books/9780429491368
856 42 - ELECTRONIC LOCATION AND ACCESS
Materials specified OCLC metadata license agreement
Uniform Resource Identifier http://www.oclc.org/content/dam/oclc/forms/terms/vbrl-201703.pdf

No items available.

2017 | The Technical University of Kenya Library | +254(020) 2219929, 3341639, 3343672 | library@tukenya.ac.ke | Haile Selassie Avenue